Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). Accessed September 30, 2020. Available at: https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf
Ganatra S , Hammond SP , Nohria A . The novel coronavirus disease (COVID-19) threat for patients with cardiovascular disease and cancer. JACC CardioOncol 2020;2:350–355.
Ganatra S , Dani SS , Shah S , et al.. Management of cardiovascular disease during coronavirus disease (COVID-19) pandemic. Trends Cardiovasc Med 2020;30:315–325.
Kuderer NM , Choueiri TK , Shah DP , et al.. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet 2020;395:1907–1918.
Liang W , Guan W , Chen R , et al.. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol 2020;21:335–337.
Guan WJ , Ni ZY , Hu Y , et al.. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020;382:1708–1720.
Zhou F , Yu T , Du R , et al.. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395:1054–1062.
Addison D , Campbell CM , Guha A , et al.. Cardio-oncology in era of the COVID-19 pandemic and beyond [published online July 27, 2020]. J Am Heart Assoc, doi: 10.1161/JAHA.120.017787
Yu J , Ouyang W , Chua MLK , et al.. SARS-CoV-2 transmission in patients with cancer at a tertiary care hospital in Wuhan, China. JAMA Oncol 2020;6:1108–1110.
Meng Y , Lu W , Guo E , et al.. Cancer history is an independent risk factor for mortality in hospitalized COVID-19 patients: a propensity score-matched analysis. J Hematol Oncol 2020;13:75.
Dai M , Liu D , Liu M , et al.. Patients with cancer appear more vulnerable to SARS-CoV-2: a multicenter study during the COVID-19 outbreak. Cancer Discov 2020;10:783–791.
Mehta V , Goel S , Kabarriti R , et al.. Case fatality rate of cancer patients with COVID-19 in a New York hospital system. Cancer Discov 2020;10:935–941.
Lee LYW , Cazier JB , Angelis V , et al.. COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study. Lancet 2020;395:1919–1926.
Guo T , Fan Y , Chen M , et al.. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol 2020;5:811–818.
Inciardi RM , Adamo M , Lupi L , et al.. Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy. Eur Heart J 2020;41:1821–1829.
Mancia G , Rea F , Ludergnani M , et al.. Renin-angiotensin-aldosterone system blockers and the risk of COVID-19. N Engl J Med 2020;382:2431–2440.
DeSantis CE , Lin CC , Mariotto AB , et al.. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin 2014;64:252–271.
Ganatra S , Hayek SS . Cardio-oncology for GenNext: a missing piece of the training puzzle. J Am Coll Cardiol 2018;71:2977–2981.
Curigliano G , Lenihan D , Fradley M , et al.. Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations. Ann Oncol 2020;31:171–190.